LOW DOSE INTERLEUKIN 2 EXPANDS PLASMABLASTS WITH A REGULATORY B CELL PHENOTYPE POST-MT

被引：0
|
作者：
O'Brien, James [1 ]
Case, Ayden [1 ]
Sriranjan, Rochelle [1 ]
Tuong, Zewen Kelvin [1 ]
Cheriyan, Joseph [1 ]
Clatworthy, Menna [1 ]
Mallat, Ziad [1 ]
Zhao, Tian [1 ]
机构：
[1] Univ Cambridge, Med, Cambridge, England
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG041
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Low-Dose Interleukin-2 Administration Improves Neuropathic Pain Behavior and Increases Regulatory T Cells Proportion
    Zhao, Yifei
    Shen, Le
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 1721 - 1722
  • [32] Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
    Meguri, Yusuke
    Asano, Takeru
    Yoshioka, Takanori
    Iwamoto, Miki
    Ikegawa, Shuntaro
    Sugiura, Hiroyuki
    Kishi, Yuriko
    Nakamura, Makoto
    Sando, Yasuhisa
    Kondo, Takumi
    Sumii, Yuichi
    Maeda, Yoshinobu
    Matsuoka, Ken-ichi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia
    Thoren, Fredrik B.
    Romero, Ana I.
    Brune, Mats
    Hellstrand, Kristoffer
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (09) : 1217 - 1223
  • [34] BIOLOGICAL MONITORING OF LOW-DOSE INTERLEUKIN-2 IN HUMANS - SOLUBLE INTERLEUKIN-2 RECEPTORS, CYTOKINES, AND CELL-SURFACE PHENOTYPES
    HANNINEN, EL
    KORFER, A
    HADAM, M
    SCHNEEKLOTH, C
    DALLMANN, I
    MENZEL, T
    KIRCHNER, H
    POLIWODA, H
    ATZPODIEN, J
    CANCER RESEARCH, 1991, 51 (23) : 6312 - 6316
  • [35] Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
    Savchenko, Andrei A.
    Kudryavtsev, Igor V.
    Isakov, Dmitry V.
    Sadowski, Ivan S.
    Belenyuk, Vasily D.
    Borisov, Alexandr G.
    PHARMACEUTICALS, 2023, 16 (04)
  • [36] Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma
    A Pession
    A Prete
    F Locatelli
    S Pierinelli
    AL Pession
    R Maccario
    E Magrini
    B De Bernardi
    P Paolucci
    G Paolucci
    British Journal of Cancer, 1998, 78 : 528 - 533
  • [37] The Interleukin-10 (IL-10) Producing Regulatory B Cell ("B10 cell") Compartment Expands with Disease Activity in Juvenile Dermatomyositis (JDM) and Pediatric-Onset Systemic Lupus Erythematosus (pSLE)
    Kalampokis, Ioannis
    Dvergsten, Jeffrey A.
    Tedder, Thomas
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S138 - S138
  • [38] A spontaneous mutation with low B cell phenotype discovered during the analysis of the function of Themis2 in B cells
    Hartweger, H.
    Peirce, M.
    Peperzak, V.
    Tarlinton, D.
    Tybulewicz, V.
    IMMUNOLOGY, 2012, 137 : 326 - 326
  • [39] Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis
    Goettel, Jeremy
    Kotlarz, Daniel
    Illig, David
    Canavan, James
    Allegretti, Jessica
    Hamilton, Matthew
    Kelly, Ryan
    Griffith, Alexandra
    Carellas, Madeline
    Nelina, Anastasia
    Bousvaros, Athos
    Korzenik, Joshua
    Snapper, Scott
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S4 - S4
  • [40] Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
    Takezawa, Yuta
    Izumi, Kouji
    Shimura, Yusuke
    Aerken, Maolake
    Natsagdorji, Ariunbold
    Iijima, Masashi
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Narimoto, Kazutaka
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2016, 36 (09) : 4961 - 4964
12345